The Alpha-1 Foundation's and University of Florida's Alpha-1 Coded Testing (ACT) Study
Status: Recruiting
Location: See location...
Intervention Type: Procedure
Study Type: Observational
SUMMARY
The Alpha-1 Coded Testing (ACT) Study was established to study genetic testing and outcomes of individuals at risk for alpha-1 antitrypsin deficiency.
Eligibility
Participation Requirements
Sex: All
Healthy Volunteers: t
View:
• Individuals of any age at risk for alpha-1 antitrypsin deficiency on the basis of symptoms or family genetic risk.
Locations
United States
Florida
University of Florida
RECRUITING
Gainesville
Contact Information
Primary
Michelle Owens, RN, BSN
Sandra.Owens@medicine.ufl.edu
352-273-6339
Backup
Allison Faunce, B.A.
Allison.Faunce@medicine.ufl.edu
352-273-8666
Time Frame
Start Date: 2001-01
Estimated Completion Date: 2050-01
Participants
Target number of participants: 50000
Authors
Charlie Strange, Mark Brantly
Related Therapeutic Areas
Sponsors
Leads: University of Florida